Immunologic effects of cyclophosphamide treatment in rheumatoid arthritis.
D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D001799:Blood Sedimentation; D046508:Culture Techniques; D003520:Cyclophosphamide / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007109:Immunity / Q000187:drug effects; D007111:Immunity, Cellular / Q000187:drug effects; D007136:Immunoglobulins / Q000032:analysis; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D007958:Leukocyte Count; D008213:Lymphocyte Activation / Q000187:drug effects; D008297:Male; D012217:Rheumatoid Factor
D007136:Immunoglobulins; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D012217:Rheumatoid Factor